Highlights and Quick Summary
- R&D Expenses for the quarter ending September 30, 2022 was $16 Million (a -19.59% decrease compared to previous quarter)
- Year-over-year quarterly R&D Expenses decreased by -27.74%
- Annual R&D Expenses for 2021 was $78.3 Million (a 26.28% increase from previous year)
- Annual R&D Expenses for 2020 was $62 Million (a 13.37% increase from previous year)
- Annual R&D Expenses for 2019 was $54.7 Million (a 68.32% increase from previous year)
- Twelve month R&D Expenses ending September 30, 2022 was $75.3 Million (a -3.43% decrease compared to previous quarter)
- Twelve month trailing R&D Expenses decreased by -3.93% year-over-year
Trailing R&D Expenses for the last four month:
30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
---|---|---|---|
$75.3 Million | $77.9 Million | $77 Million | $78.3 Million |
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical R&D Expenses of Atreca, Inc.
Most recent R&D Expensesof BCEL including historical data for past 10 years.Interactive Chart of R&D Expenses of Atreca, Inc.
Atreca, Inc. R&D Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | $16.05 | $19.95 | $17.06 | – |
2021 | $22.2 | $18.72 | $19.04 | $18.39 | $78.35 |
2020 | $16.85 | $16.81 | $14.18 | $14.21 | $62.05 |
2019 | $14.28 | $12.81 | $15.92 | $11.71 | $54.73 |
2018 | – | – | $7.82 | $7.42 | $32.51 |
2017 | – | – | – | – | $23.67 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology